![]() |
市場調查報告書
商品編碼
1559475
手動人工呼吸器:市場洞察·競爭環境·市場預測 (~2030年)Manual Resuscitator - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
在 2024 年至 2030 年的預測期內,手動復甦器市場規模預計將以 6.13% 的複合年增長率增長。
手動復甦器市場由幾個關鍵因素推動,包括心肺和呼吸系統疾病(如心臟驟停和慢性阻塞性肺病(COPD))發病率的增加。院外心臟驟停、創傷和事故的高發生率也增加了對緊急手動復甦器的需求。此外,老年人口的增加以及全球製造商不斷推出新型和改進的手動復甦器也推動了預測期內的市場成長。
根據英國復甦委員會提供的最新數據,2021 年院外心臟驟停 (OHCA) 的年發生率約為每 10 萬人中 55 例。大多數心臟驟停 (72%) 發生在家裡,另外 15% 發生在工作中。大多數心臟驟停 (98%) 發生在成年人中,其中三分之一 (33%) 年齡在 15 歲至 64 歲之間。院內心臟驟停 (IHCA) 的年發生率為每 1,000 名住院患者 1 至 1.5 例。 IHCA 患者的平均年齡為 70 歲,四分之一(26.7%)的年齡在 16 歲至 64 歲之間。院外和院內心臟驟停發生率的不斷增加凸顯了對手動復甦器的迫切需求。醫療保健提供者、急救人員和公共衛生組織越來越注重提高生存率和患者治療效果,從而推動了對高品質手動復甦器的需求。此外,人們對即時回應能力的認識提高和迫切需要直接促使對手動復甦器的需求激增,刺激了市場成長和復甦技術的創新。
根據世界衛生組織最新數據(2023年),全球慢性阻塞性肺病患者人數估計為3.92億。此外,根據澳洲健康與福利研究所提供的數據(2023),到2023年,COPD將佔呼吸系統疾病負擔的50%,佔總疾病負擔的3%。其佔比為6%。慢性阻塞性肺病是全世界發病和死亡的主要原因,經常導致嚴重的呼吸窘迫和急性加重,需要立即呼吸支持。隨著慢性阻塞性肺病患者數量的不斷增加,對能夠在緊急情況下提供高效可靠氧氣輸送的手動復甦器的需求也在增加,從而推動了整體市場的發展。
本報告提供全球手動人工呼吸器的市場調查,彙整市場概要,市場影響因素及市場機會分析,法律制度,市場規模的轉變·預測,各種區分·地區/各主要國家的詳細分析,競爭情形,主要企業簡介等資訊。
Manual Resuscitators Market by Type (Self-Inflating and Flow-Inflating), Usage (Disposable and Reusable), Patient (Adults, Neonatal, and Pediatric), Application (Cardiopulmonary Obstructive Disorders (COPD), Cardiac Pulmonary Arrest, and Others), End-Users (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing prevalence of cardiopulmonary obstructive disorders (COPD), increasing prevalence of cardiac pulmonary arrest, and increasing awareness about resuscitation across the globe.
The manual resuscitators market is estimated to grow at a CAGR of 6.13% during the forecast period from 2024 to 2030. The market for manual resuscitators is driven by several key factors. The increasing incidence of cardiopulmonary and respiratory conditions, such as cardiac arrest and chronic obstructive pulmonary disease (COPD). Additionally, the high incidence of out-of-hospital cardiac arrests, trauma, and accidents also drives the need for emergency manual resuscitators. Further, the growing geriatric population and continuous introduction of new and improved manual resuscitators by manufacturers worldwide are propelling market growth during the forecast period from 2024 to 2030.
Manual Resuscitators Market Dynamics
According to the latest data provided by the Resuscitation Council UK (2021), in 2021, the annual incidence of out-of-hospital cardiac arrest (OHCA) was approximately 55 per 100,000 inhabitants. Most cardiac arrests (72%) occur in the home, with an additional 15% occurring in the workplace. The vast majority of cardiac arrests (98%) occur in adults, with one-third (33%) of these adults aged 15-64 years. The annual incidence of in-hospital cardiac arrest (IHCA) is 1 to 1.5 per 1,000 hospital admissions. The average age of individuals sustaining an IHCA is 70 years, with a quarter (26.7%) aged 16-64 years. Thus, the rising incidence of both out-of-hospital and in-hospital cardiac arrests underscored the critical need for manual resuscitators. Healthcare providers, emergency responders, and public health organizations are increasingly focused on improving survival rates and patient outcomes, driving the demand for high-quality manual resuscitators. Additionally, the heightened awareness and the critical need for immediate response capabilities directly translate into a surge in demand for manual resuscitators, fueling market growth and innovation in resuscitation technologies.
Additionally, as per the latest data provided by the World Health Organization (2023), it was estimated that there were 392 million cases of COPD globally. Furthermore, as per the data provided by the Australian Institute of Health and Welfare (2023), COPD accounted for 3.6% of the total disease burden from 50% of the burden of respiratory conditions in 2023. COPD, a leading cause of morbidity and mortality worldwide, often leads to severe respiratory distress and acute exacerbations that require immediate respiratory support. As the number of COPD patients rises, so does the demand for manual resuscitators which are capable of providing efficient and reliable oxygen during emergencies thereby boosting the overall market.
Additionally, the market is expected to see a boost from the approval of newly developed resuscitators. For instance, in October 2022, Laerdal Medical announced that its NeoNatalie Resuscitator received approval under the new EU Medical Device Regulation (MDR). Thus, the increasing product approvals and new launches boost the market for manual resuscitators by expanding reach, increasing product visibility, optimizing distribution, offering targeted sales and support, and creating market differentiation and competitive advantages.
However, the complications associated with manual resuscitators and the presence of alternative methods that provide respiratory support in emergencies may result in slight obstacles to the growth of the manual resuscitators market.
Manual Resuscitators Market Segment Analysis:
Manual Resuscitators Market by Type (Self-Inflating and Flow-Inflating), Usage (Disposable and Reusable), Patient (Adults, Neonatal, and Pediatric), Application (Cardiopulmonary Obstructive Disorders (COPD), Cardiac Pulmonary Arrest, and Others), End-Users (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the patient segment of the manual resuscitators market, the neonatal category is estimated to have a significant revenue share in the manual resuscitators market in 2023. The applications of neonatal resuscitators provide effective respiratory support tailored to the delicate needs of newborn infants. These resuscitators are designed to accommodate the unique physiology of newborns, including their smaller airways and respiratory requirements. Neonatal resuscitators are user-friendly and are often designed for ease of use in high-stress environments such as delivery rooms and NICUs. Neonatal resuscitators are boosting the overall resuscitator market more significantly due to the critical need for effective neonatal care. The specialized nature of these devices, coupled with increased awareness, regulatory support, and focused investments in neonatal healthcare infrastructure, drives their higher market demand and growth compared to other types of resuscitators.
Additionally, the rising number of preterm births, which often require respiratory support, further boosts the market for neonatal resuscitation devices. For instance, as per the latest data provided by the World Health Organization (2023), an estimated 13.4 million babies were born preterm in 2020. Furthermore, as per the data provided by the Pan America Health Organization (2023), of every 10 babies born, 1 is preterm and every 40 seconds, 1 of those babies dies across the world. The underdeveloped lungs of preterm infants are not fully equipped to handle the transition to breathing air outside the womb. As a result, many premature babies experience respiratory distress syndrome, thus the need for resuscitators in preterm infants is further increased thereby boosting the market of infant resuscitators and thus boosting the overall market of resuscitators.
Thus, due to the above-mentioned factors, the neonatal category is estimated to amass significant revenue, which will further in return boost the market for manual resuscitators during the forecast period.
North America Is Expected To Dominate The Overall Manual Resuscitators Market:
North America is expected to account for the highest proportion of the manual resuscitators market in 2023, out of all regions. The burgeoning market for manual resuscitators is underpinned by a complex interplay of factors, each contributing to its rapid expansion. Chronic obstructive pulmonary disease (COPD) and cardiac pulmonary arrest are significant health challenges that drive the demand for manual resuscitators in North America. COPD, affects millions of people in the region, leading to frequent exacerbations that require immediate respiratory support. Furthermore, the growing awareness and implementation of resuscitation education programs further enhances the market for manual resuscitators by emphasizing the importance of early intervention and proper resuscitation techniques.
According to recent data provided by the Heart and Stroke Statistics (2022), there were more than 356,000 out-of-hospital cardiac arrests (OHCA) annually in the U.S. The incidence of emergency medical services-assessed non-traumatic OHCA in people of any age is estimated to be 356,461, or nearly 1,000 people each day. Thus, the data serve as a compelling driver for the manual resuscitator market in the region. Healthcare providers, emergency responders, and public health organizations are increasingly recognizing the need for quick and effective intervention in cardiac arrest scenarios. This recognition is likely to spur investments in resuscitators that can enhance the chances of survival for cardiac arrest victims thereby boosting the market for manual resuscitators in the region.
As per the recent data provided by American Lung Association (2024) findings, approximately 1.7 million adults, constituting 4.6% of the adult population of the US, had reported a diagnosis of COPD, encompassing chronic bronchitis or emphysema. Notably, there was a higher prevalence of COPD among women than men, as well as among individuals aged 65 and older compared to younger age brackets. In conclusion, the rising prevalence of COPD in the US is anticipated to fuel the growth of the manual resuscitator market in the US, which will in return fuel the market growth for manual resuscitators in North America.
Thus, the above mentioned factors are expected to escalate the market of manual resuscitators in the region.
Manual Resuscitators Market Key Players:
Some of the key market players operating in the manual resuscitators market include Vyaire Medical Inc., Ambu A/S, Teleflex Inc., Zeal Medical Private Limited, Medline Industries Inc., Allied Healthcare, GE Healthcare, Drager Medical AG and Co., Laerdal Medical, Hopkins Medical Products, Mercury Medical, Cardinal Health, Bayer AG, McKesson Corporation, Romsons, and others.
Recent Developmental Activities In The Manual Resuscitators Market:
Key Takeaways From The Manual Resuscitators Market Report Study
Target Audience Who Can Be Benefited From This Manual Resuscitators Market Report Study
Frequently Asked Questions For The Manual Resuscitators Market:
Manual resuscitators, also known as bag-valve-mask (BVM) devices or self-inflating bags, are essential medical devices used to provide positive pressure ventilation to patients who are not breathing adequately or are in respiratory distress. These devices are commonly used in emergency and critical care settings, including hospitals, ambulances, and clinics.
The manual resuscitators market is estimated to grow at a CAGR of 6.13% during the forecast period from 2024 to 2030.
The market for manual resuscitators is driven by several key factors. The increasing incidence of cardiopulmonary and respiratory conditions, such as cardiac arrest and chronic obstructive pulmonary disease (COPD). Additionally, the high incidence of out-of-hospital cardiac arrests, trauma, and accidents also drives the need for emergency manual resuscitators. Further, the growing geriatric population and continuous introduction of new and improved manual resuscitators by manufacturers worldwide are propelling market growth during the forecast period from 2024 to 2030.
Some of the key market players operating in the manual resuscitators are Vyaire Medical Inc., Ambu A/S, Teleflex Inc., Zeal Medical Private Limited, Medline Industries Inc., Allied Healthcare, GE Healthcare, Drager Medical AG and Co., Laerdal Medical, Hopkins Medical Products, Mercury Medical, Cardinal Health, Bayer AG, McKesson Corporation, Romsons, and others.
North America is expected to account for the highest proportion of the manual resuscitators market in 2023, out of all regions. The rising prevalence of chronic obstructive pulmonary disease (COPD) and cardiac pulmonary arrest is a major driver boosting the demand for manual resuscitators in North America. Furthermore, the growing awareness and implementation of resuscitation education programs enhance the market for manual resuscitators by emphasizing the importance of early intervention and proper resuscitation techniques.